Our Mission

The PCCTC’s distinguished investigators work together on a single mission: to design, implement, and complete hypothesis-driven prostate cancer studies, translating scientific discoveries to improved standards of care. We offer contract research organization (CRO) services and leverage academic consortium engagement to carry out this mission, ensuring efficient study selection, reporting, site management, clinical operations, and data analyses.

Our History

The PCCTC was initiated in 2005 by the Prostate Cancer Foundation (PCF) and the U.S. Department of Defense (DOD) Prostate Cancer Research Program (PCRP) in response to critically unmet needs in prostate cancer clinical research identified by physician investigators and patient advocates. To fulfill our mission, we developed a unique infrastructure which has fostered a culture of transparent project co-development between investigators, research sites, and industry partners. Established as an independent entity in 2014, the PCCTC, LLC is now the nation’s premier multicenter contract research organization (CRO) and academic clinical consortium specializing in cutting-edge prostate cancer research. Through the collaborative nature and intellectual synergy of our leadership, the PCCTC remains poised to make a significant impact on the lives of patients by keeping the pipeline primed with the most promising novel therapies and validated biomarkers

PCCTC investigator-led studies represent >22% of active early-phase prostate cancer clinical trials in the US.

The PCCTC has contributed to the advancement of 27 therapeutic candidates to phase 3 study, nine of which are fully approved by the FDA.

PCCTC research has resulted in the publication of over 500 abstracts and 190 academic papers.

Over 16,200 participants have been enrolled onto 305 PCCTC studies.

Our Leadership

Management Team

Jake Vinson
CEO

Rebecca Green
Director of Clinical Strategy and Operations

Howard I. Scher, MD
Scientific Oversight Committee Chair Emeritus

Michelle Karlin
Director of Business Development and Operations

Michael J. Morris, MD
Scientific Oversight Committee Chair

Joy Allen, PhD
Director of Clinical Data Management

Sarah Wise
Senior Director of Research Operations

Charles J. Ryan, MD

Medical Director

Travis Gerke, ScD
Director of Clinical Data Science

Scientific Oversight Committee

Michael J. Morris, MD (Chair), Memorial Sloan Kettering Cancer Center

Mary-Ellen Taplin, MD, Dana-Farber / Harvard Cancer Center

Andrew Armstrong, MD, MSc, Duke Comprehensive Cancer Center

Channing Paller, MD, Johns Hopkins Sidney Kimmel
Comprehensive Cancer Center

Alexandra Sokolova, MD, Oregon Health and Science University
Knight Cancer Institute

Rahul Aggarwal, MD, University of California, San Francisco

Russell Szmulewitz, MD, University of Chicago

Emmanuel Antonarakis, MD, University of Minnesota Twin Cities

Heather Cheng, MD, PhD, University of Washington Fred Hutchinson
Cancer Research Center

Glenn Liu, MD, University of Wisconsin Carbone Cancer Center

Frank Cackowski, MD, PhD, Barbara Ann Karmanos Cancer Institute

Scott Tagawa, MD, MS, Weill Cornell Medical College & Columbia University

Our Participating Clinical Research Sites

Over 200 clinical research sites—academic medical centers, community hospitals, and research institutions—collaborate on PCCTC studies.

Current list available upon request.

US

Arizona Urology Specialists

Atrium Health

Baptist Clinical Research Institute

Baylor College of Medicine

Boca Raton Hospital

California Research Institute

Carolina Urologic Research Center

Chesapeake Urology Research Associates

Christiana Care Health Services, Inc

City of Hope

Cleveland Clinic Foundation

Columbia University

Comprehensive Cancer Centers of Nevada

Dana-Farber Cancer Institute

Dayton Physician's Network

Delnor Cancer Center

Doylestown Health

Duke Cancer Institute

Durham VA Medical Center

Easton Hospital

Florida Urology Partners

Fox Chase Cancer Center - Temple Health

Hematology & Oncology Associates of the Treasure Cost

Houston Methodist Research Institute

Howard University

Indiana University

Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center

Karmanos Cancer Institute

Kishwaukee Cancer Center

Lahey Clinic

Lifespan Health - Brown University

Mayo Clinic – Arizona

Mayo Clinic – Jacksonville

Mayo Clinic – Rochester

MD Anderson / Banner Health

MD Anderson / Cooper Health

Medical University of South Carolina

INTERNATIONAL

A Beneficiência Portuguesa de São Paulo (Brazil)

Alfred Health (Australia)

Arthur J.E. Child Comprehensive Cancer Center (Canada)

Australian Prostate Centre (Australia)

Australian Urology Associates (Australia)

BC Cancer Agency (Canada)

Beacon Hospital (Ireland)

Canisius Wilhelmina Ziekenhuis (The Netherlands)

Centre Hospitalier de l'Université de Montréal (Canada)

Centro de Paulista de Oncologia (Brazil)

Centro de Pesquisa em Oncologia (Brazil)

Centro de Pesquisa São Lucas (PUCRS) (Brazil)

Chris O'Brien Lifehouse (Australia)

CHU de Québec-Université Laval (Canada)

Clatterbridge Cancer Centre NHS Foundation Trust (UK)

Consorci Hospitalari Provincial de Castelló (Spain)

Cross Cancer Institute (Canada)

Deventer Ziekenhuis (The Netherlands)

Eastern Health (Australia)

Ente Ospedaliero Cantonale (EOC) (Switzerland)

Epworth Healthcare (Australia)

Erasmus Medical Center (The Netherlands)

Federal Medical Centre Abeokuta (Nigeria)

Franciscus Gasthuis (The Netherlands)

Fundación Instituto Valenciano De Oncología (Spain)

Groote Schuur Hospital (South Africa)

Guy’s and St Thomas’ NHS Foundation Trust (UK)

Hospital 12 de Octubre (Spain)

Hospital Beneficência Portuguesa (Brazil)

Hospital Clínic de Barcelona (Spain)

Hospital Clinico San Carlos (Spain)

Hospital Das Clínicas Da Universidade Federal De Minas Gerais (HC-UFMG) (Brazil)

Hospital de Amor de Barretos (Brazil)

Hospital del Mar (Spain)

Hospital Erasto Gaertner (Brazil)

Hospital Israelita Albert Einstein (Brazil)

Memorial Sloan Kettering Cancer Center

Memphis VA Medical Center

Midlantic Urology

Millennium Oncologists

Moffitt Cancer Center

Morehouse School of Medicine

Mount Sinai Medical Center - Miami

Nebraska Cancer Specialists

Nevada Cancer Research Foundation (SNCRF)

New Jersey Urology / Summit Health

New Mexico Oncology & Hematology Consultants

New York University

NewYork–Presbyterian Brooklyn Methodist Hospital

NorthShore University Health System

Northwestern Medicine Warrenville & Delnor

Ochsner Health

Ohio State University

Oncology & Hematology Associates of Southwest Virginia

Oregon Health & Sciences University Knight Cancer Institute

Ralph H. Johnson VA Medical Center

Reading Health System

Rhode Island Hospital

Robert H. Lurie Comprehensive Cancer Center Northwestern University

Rocky Mountain Cancer Centers

Roswell Park Comprehensive Cancer Center

Rush University Medical Center

Rutgers University Cancer Institute of New Jersey

San Bernadino Urological Associates

SUNY Buffalo

Tennessee Cancer Specialists

The University of Chicago

Thomas Jefferson University - Sidney Kimmel Cancer Center

Tulane University

University Hospitals Cleveland Medical Center

Hospital Moinhos de Vento (Brazil)

Hospital Universitario 12 de Octubre (Spain)

Hospital Universitario Central de Asturias (Spain)

Hospital Universitario La Princesa (Spain)

Hospital Universitario Miguel Servet (Zaragoza) (Spain)

Hospital Universitario Ramón y Cajal (Spain)

Hospital Universitario Virgen de la Victoria (Spain)

Hospital University Virgen del Rocio (Spain)

Hunting-St. Antonius (Netherlands)

IMIP Andrea Lopes (Brazil)

Institut Catalá d’Oncologia Badalona (Spain)

Instituto Brasileiro de Controle do Câncer (Brazil)

Instituto Câncer do Estado de São Paulo (Brazil)

Instituto do Câncer e Transplante (Brazil)

Instituto Valenciano de Oncología (Spain)

Isala Ziekenhuis (The Netherlands)

Jewish General Hospital (Canada)

Juravinski Cancer Centre (Canada)

Kantonsspital Grabünden (Switzerland)

Kantonsspital St. Gallen (Switzerland)

Lagos State University Teaching Hospital (Nigeria)

Lancashire Teaching Hospitals NHS Foundation Trust (UK)

Lister Hospital (UK)

Maasstad Ziekenhuis (The Netherlands)

Macquarie University Hospital (Australia)

MC Haaglanden (The Netherlands)

Mount Vernon Cancer Centre (UK)

Nederlands Kanker Instituut / Antoni van Leeuwenhoek Ziekenhuis (The Netherlands)

Noordwest Ziekenhuisgroep (NWZ) Alkmaar (The Netherlands)

Northern Health (Australia)

Onkozentrum Zürich (Switzerland)

Örebro University Hospital (Sweden)

Oslo University Hospital (Norway)

Ottawa Hospital Cancer Centre (Canada)

Peter MacCallum Cancer Centre (Australia)

Princess Alexandra Hospital (Australia)

Princess Margaret Cancer Center (Canada)

Prostate Cancer Centre (Canada)

University of Alabama-Birmingham

University of Alabama-Tuscaloosa

University of California, Davis

University of California, Los Angeles

University of California, San Diego

University of California, San Francisco

University of Cincinnati

University of Florida

University of Illinois at Chicago

University of Maryland

University of Massachusetts

University of Massachusetts Memorial Medical Center

University of Michigan

University of Minnesota

University of Mississippi Medical Center

University of New Mexico

University of North Carolina

University of Oklahoma Stephenson Cancer Center

University of Rochester Medical Center

University of Texas, Southwestern Medical Center

University of Utah

University of Virginia

University of Washington - Fred Hutch Cancer Center

University of Wisconsin - Carbone Cancer Center

Urology San Antonio - USA Clinical Trials

VA of Western New York Healthcare System

Virginia Cancer Specialists

Virginia Oncology Associates

Warrenville Cancer Center

Washington University in St. Louis

Weill Cornell Medical Center

William Jennings Bryan Dorn VA Medical Center

Winship Cancer Institute Emory University

XCancer Network

Yale University

Redland Hospital (Australia)

Rosebank Oncology (South Africa)

Royal Brisbane & Women’s Hospital (Australia)

Servicio de Salud del Principado de Asturias, SESPA  (Spain)

Sheffield Teaching Hospitals NHS Foundation Trust (UK)

Skåne University Hospital (Sweden)

Sligo University Hospital (Ireland)

Sociedade Campineira de Educação e Instrução (SCEI) (Brazil)

South Tyneside District Hospital (UK)

St. Vincent’s Hospital Sydney (Australia)

St. Vincent’s University Hospital (Ireland)

Steve Biko Academic Hospital (South Africa)

Stichting Amphia (The Netherlands)

Stichting Ziekenhuisgroep Twente (ZGT) (The Netherlands)

Sunderland Royal Hospital (UK)

Tacchini Hospital (Brazil)

Tallaght University Hospital (Ireland)

Ter Gooi Ziekenhuis (The Netherlands)

The Canberra Hospital (Australia)

The Christie NHS Foundation Trust (UK)

The Royal Marsden NHS Foundation Trust (UK)

The University of the West Indies – Cave Hill Campus (Barbados)

The University Of the West Indies – Mona Campus (Jamaica)

Umeå University Hospital (Sweden)

Universitätsspital Basel (Switzerland)

Universitätsspital Zürich (Switzerland)

University Hospital Southampton NHS Foundation Trust (UK)

University Hospitals of Morecambe Bay NHS Trust (UK)

University of Ilorin Teaching Hospital (Nigeria)

University of Maiduguri Teaching Hospital (Nigeria)

University of Nairobi (Kenya)

Vall D'Hebron Institut d'Oncologia (VHIO) (Spain)

Velindre Cancer Centre (UK)

Westmead Hospital (Australia)